Join the DDA or

Crescent Pharma Paroxetine 40mg Tablets recall issued

Specific batch in Class 2 alert

April 29th 2022

Tagged: MHRA alert


Crescent Pharma Ltd is recalling a specific batch of Paroxetine 40mg Film Coated Tablets (30s) as a precautionary measure. This is due to out of specification results for dissolution during routine stability testing.

The affected batch is Batch Number 06309, with expiry September 2023. The batch was first distributed in February 2022.

The batch should no longer be supplied, with immediate effect. However, patients already dispensed this batch should continue taking the tablets, as stopping paroxetine treatment abruptly is likely to cause harm.

Further information is available on 01256 772730.